S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
Log in

NASDAQ:CTHRCharles & Colvard, Ltd. Stock Price, Forecast & News

$0.69
-0.02 (-3.48 %)
(As of 08/11/2020 01:05 PM ET)
Add
Compare
Today's Range
$0.68
Now: $0.69
$0.72
50-Day Range
$0.69
MA: $0.71
$0.73
52-Week Range
$0.60
Now: $0.69
$1.66
Volume8,842 shs
Average Volume220,251 shs
Market Capitalization$20.00 million
P/E RatioN/A
Dividend YieldN/A
Beta0.32
Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelry featuring moissanite worldwide. The company offers near-colorless moissanite jewels cut in various shapes, including round, square brilliant, princess, cushion, radiant, pear, marquise, heart, and oval in sizes ranging from approximately 1.3 to 12 millimeters. It also provides finished jewelry featuring moissanite, such as stud earrings, solitaire and three-stone rings, pendants, and bracelets. The company primarily offers its products under the Charles & Colvard Created Moissanite, Forever Classic, Forever Brilliant, and Forever One brand names. It sells its products through distributors, manufacturers, retailers, television shopping networks, and designers, as well as at retail to end consumers through its direct-to-consumer e-commerce site, charlesandcolvard.com, third-party online marketplaces, drop-ship, and e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is based in Morrisville, North Carolina.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Jewelry, silverware, & plated ware
Sub-IndustryN/A
Current SymbolNASDAQ:CTHR
CUSIPN/A
Phone919-468-0399

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.24 million
Cash Flow$0.09 per share
Book Value$1.60 per share

Profitability

Net Income$2.27 million

Miscellaneous

Employees59
Market Cap$20.00 million
Next Earnings Date9/3/2020 (Estimated)
OptionableNot Optionable
$0.69
-0.02 (-3.48 %)
(As of 08/11/2020 01:05 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for CTHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Charles & Colvard, Ltd. (NASDAQ:CTHR) Frequently Asked Questions

How has Charles & Colvard, Ltd.'s stock price been impacted by Coronavirus?

Charles & Colvard, Ltd.'s stock was trading at $0.7553 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CTHR shares have decreased by 8.6% and is now trading at $0.6901.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Charles & Colvard, Ltd.?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Charles & Colvard, Ltd.
.

When is Charles & Colvard, Ltd.'s next earnings date?

Charles & Colvard, Ltd. is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020.
View our earnings forecast for Charles & Colvard, Ltd.
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) announced its earnings results on Thursday, May, 21st. The company reported ($0.03) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.01. The company earned $6.49 million during the quarter, compared to analysts' expectations of $6 million. Charles & Colvard, Ltd. had a negative net margin of 15.36% and a positive return on equity of 0.71%.
View Charles & Colvard, Ltd.'s earnings history
.

Has Charles & Colvard, Ltd. been receiving favorable news coverage?

Media stories about CTHR stock have been trending neutral this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Charles & Colvard, Ltd. earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term.
View the latest news about Charles & Colvard, Ltd.
.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 40,500 shares, an increase of 32.4% from the January 31st total of 30,600 shares. Based on an average daily trading volume, of 147,400 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.2% of the company's shares are short sold.
View Charles & Colvard, Ltd.'s Short Interest
.

Who are some of Charles & Colvard, Ltd.'s key competitors?

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Amplify Energy (AMPY), Amplify Energy (AMPY), Gran Tierra Energy (GTE), Novan (NOVN), Pennsylvania R.E.I.T. (PEI) and BioNano Genomics (BNGO).

Who are Charles & Colvard, Ltd.'s key executives?

Charles & Colvard, Ltd.'s management team includes the following people:
  • Ms. Suzanne T. Miglucci, CEO, Pres & Director (Age 58)
  • Mr. Clint J. Pete, CFO & Treasurer (Age 57)
  • Mr. Don O'Connell, COO & Sr. VP of Supply Chain (Age 53)
  • Mr. John Lane, VP of Marketing
  • Mr. Randall N. McCullough, Advisory Consulting (Age 67)

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a number of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.24%). Company insiders that own Charles & Colvard, Ltd. stock include Anne M Butler, Clint J Pete, Don O'connell, Jaqui Lividini, Ollin B Sykes and Suzanne Miglucci.
View institutional ownership trends for Charles & Colvard, Ltd.
.

Which institutional investors are buying Charles & Colvard, Ltd. stock?

CTHR stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Charles & Colvard, Ltd. stock in the last two years include Clint J Pete, Don O'connell, Jaqui Lividini, Ollin B Sykes, and Suzanne Miglucci.
View insider buying and selling activity for Charles & Colvard, Ltd.
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $0.69.

How big of a company is Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. has a market capitalization of $20.00 million and generates $32.24 million in revenue each year. The company earns $2.27 million in net income (profit) each year or $0.10 on an earnings per share basis. Charles & Colvard, Ltd. employs 59 workers across the globe.

What is Charles & Colvard, Ltd.'s official website?

The official website for Charles & Colvard, Ltd. is www.charlesandcolvard.com.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at 919-468-0399 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.